Robinson James George's Form 4/A amendment
AmendedNymox Pharmaceutical Corp (NYMXF) · filed May 18, 2023
- Accession no.
- 0001729637-23-000003
- Filed
- May 18, 2023, 4:09 PM ET
- Trade date
- Apr 25, 2023
- Filing delay
- 23 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Apr 27, 2023
This filing lists 1 non-derivative transaction. Open-market purchases total $18.0K. It was filed 23 days after the trade.
This filing was later replaced by the amendment 0001729637-23-000006 (Jun 26, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robinson James GeorgeCIK 0001651844 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Common Stock | PPurchaseAcquired | +40,000 | $0.45 | +$18,000 | 4,742,065 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.